Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Clinical trial NCT00840801 · COMPLETED

Trial details

NCT number: NCT00840801
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Encephalitis, Tick-Borne

Start date: 2009-02-06
Primary completion: 2010-05-20
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.